Surgical Science is a medical simulation company that develops ready-to-use simulators and evidence-based, customizable curricula for healthcare professionals. The company provides educational products to enhance proficiency and patient safety, as well as tailor-made simulation solutions embedded into products for the MedTech industry. Surgical Science collaborates with leading MedTech companies worldwide to meet specific product needs and works with the medical community to ensure simulation accuracy. The company focuses on computer-based simulations and complementary technologies to support structured training curricula globally.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Medical Devices Homepage surgicalscience.com
Sector Healthcare IR page surgicalscience.com
Tags
medical simulation, healthcare training, patient safety, medtech solutions, computer-based simulation, clinical education
Press page surgicalscience.com/insights/news

Metrics

Valuation  
Market cap kr 1.738B
Market cap (USD) $ 171.903M
P/E 26.00
PEG —
P/BV 0.41
P/S 1.75
P/OCF 21.78
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 1.5%
ROI 1.6%
ROIC 1.6%
Profit margin 6.7%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) -29.2%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 8
Quality score 17.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue 992.34M 884.08M 882.85M 802.54M 366.77M 104.79M
Net profit 66.81M 131.646M 233.972M 187.974M 86.248M 15.6M

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Surgical Science and CHEST Mark 10 Years: Transforming Chest Medicine Competency through Simulation Training for Thousands of Clinicians

GOTHENBURG, Sweden, October 21, 2026– Surgical Science, the global leader in simulation products for healthcare training, is marking its 10-year anniversary of the company’s partnership with the American College of Chest Physicians**®** (CHEST). The teams are celebrating their decade-long partnership, the launch of a new simulated curriculum, and the importance of combining education with simulation technology at the CHEST 2026 Annual Meeting in Phoenix and throughout the year at the CHEST Simulation and Training Facility in Glenview, Illinois.

“Over the last decade, we’ve worked closely with CHEST to revolutionize the education and curriculum of thousands of clinicians before they start doing procedures on human patients,” said Tom Englund, CEO of Surgical Science. “We believe this is a strong model for collaboration, combining global education programs with simulation to expand access to competency-based training for the benefit of clinicians and patients.”

Medical education is at the core of what we do at CHEST, and partnerships like this one help us meet the growing needs of our members,” said Richard Schuch, Ed.D, Chief Learning Officer & Senior Vice President, Education at the American College of Chest Physicians. “Expanding our work with Surgical Science allows us to continually enhance our educational programs and widen the breadth of our courses contributing to improved patient care and outcomes.”

Surgical Science and CHEST Joint Achievements

  • CHEST uses more than 15 Surgical Science simulators at the CHEST center and at the annual event.
  • BRONCH Express Simulator: The launch of a co-developed portable table-top version, focused on hands-on training for bronchoscopy skills and procedures.
  • CHEST Standardized Simulated Bronchoscopy Curriculum: A program for developing and tracking essential bronchoscopic skills and diagnostic bronchoscopy.
  • CHEST Simulated Curriculum for Critical Care TEE: Focused on the educational opportunity to learn and demonstrate transesophageal echocardiographic skills, awarding a Chest Certificate of Completion for performance.

Surgical Science and CHEST Future Roadmap
The teams continue to evolve training modules, including a future launch of the CHEST EBUS Curriculum, which will award CME points for a self-directed simulation performance.

About the American College of Chest Physicians
The American College of Chest Physicians® (CHEST) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication, and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 18,000+ members from around the world who provide patient care in pulmonary, critical care, and sleep medicine. For information about the American College of Chest Physicians and its family of journals, including the flagship journal CHEST®, visit chestnet.org .

About Surgical Science


One of the biggest challenges within healthcare globally is reducing injuries incurred during care. Medical education and training are key, especially as a large part of the training can now be performed outside the operating room. Surgical Science is a world leader in the development of virtual reality simulators for evidence-based training. The simulators enable surgeons and other medical specialists to train and improve their psycho-motor skills and instrument handling before entering the clinical environment. Alongside its own products, Surgical Science works with simulation solutions for medical device companies that develop instruments for clinical use, such as robotic surgery. 

Surgical Science has approximately 310 employees. The company is headquartered in Gothenburg, Sweden, and has operations in Tel Aviv, Israel; Stockholm, Sweden; Cleveland, US; and Cardiff, UK. Through sales offices in the US and China as well as a global network of distributors, Surgical Science maintains a presence in most markets. Shares in Surgical Science Sweden AB (publ) are traded on Nasdaq First North Growth Market.
www.surgicalscience.com

Valberedning i Surgical Science Sweden AB (publ) Bull 0 Bear 0 Routine

Valberedning i Surgical Science Sweden AB (publ)

Följande personer har utsetts att ingå i Surgical Sciences valberedning inför årsstämman 2027:

Åsa Hedin, utsedd av Marknadspotential AB
Roland Bengtsson, utsedd av Semelin Kapitalförvaltning AB
Anna Sundberg, utsedd av Handelsbanken Fonder

Styrelsens ordförande Gisli Hennermark kommer vara adjungerad till valberedningen förutom när valberedningen ska behandla frågan om ordförande i styrelsen.

Utnämningen har skett enligt den instruktion avseende principer för utseende av valberedning i bolaget som fastställdes vid årsstämman i Surgical Science den 16 maj 2024. De aktieägare som har utsett ledamöterna i valberedningen representerade sammanlagt drygt 35 procent av samtliga aktier i bolaget per den 31 augusti 2026.

Valberedningen ska arbeta fram förslag i följande frågor att föreläggas årsstämman för beslut: (i) förslag till stämmoordförande, (ii) förslag till styrelse, (iii) förslag till styrelseordförande, (iv) förslag till styrelsearvode med uppdelningen mellan ordförande och övriga ledamöter i styrelsen, (v) förslag till arvode för ledamöterna i ersättnings- respektive revisionsutskottet (i förekommande fall), (vi) förslag till revisor, (vii) förslag till arvodering av revisor, och (viii) i den mån så anses erforderligt, förslag till ändringar i gällande regler för valberedningen.

Årsstämma i Surgical Science Sweden AB (publ) kommer att hållas onsdagen den 19 maj 2027 i Göteborg. Aktieägare som vill lämna förslag till valberedningen är välkomna att göra det i god tid före årsstämman 2027 så att valberedningen hinner beakta förslaget. Förslag ska sändas till Surgical Science Sweden AB (publ), Att: Valberedningen, Drakegatan 7A, 412 50 Göteborg.

Göteborg den 1 oktober 2026
Surgical Science Sweden AB (publ)

Pressmeddelandet i sin helhet finns tillgängligt i bilagan eller via
https://surgicalscience.com/aktien/pressmeddelanden/

Nomination Committee of Surgical Science Sweden AB (publ)

The following members have been appointed to Surgical Sciences’ Nomination Committee for the 2027 Annual General Meeting:

Åsa Hedin, appointed by Marknadspotential AB
Roland Bengtsson, appointed by Semelin Kapitalförvaltning AB
Anna Sundberg, appointed by Handelsbanken Fonder

The Chairman of the Board, Gisli Hennermark, shall be co-opted to the Nomination Committee except when the Nomination Committee considers the matter of the Chairman of the Board.

The appointments have been made in accordance with the instructions regarding principles for the appointment of the company’s Nomination Committee established at the Annual General Meeting of Surgical Science on May 16, 2024. The shareholders that have appointed the members of the Nomination Committee represented in aggregate just above 35 percent of all shares in the company as of August 31, 2026.

The Nomination Committee shall prepare and submit proposals to the Annual General Meeting regarding: (i) election of Chairman of the Meeting, (ii) election of board members, (iii) election of Chairman of the Board, (iv) resolution on board remuneration with the division between the chairman and other members of the board, (v) resolution on remuneration for the members of the Remuneration and Audit Committee (if applicable), (vi) election of auditors, (vii) resolution on remuneration of auditors, and (viii) to the extent deemed necessary, resolution on amendments in current rules for the Nomination Committee.

The Annual General Meeting of Surgical Science Sweden AB (publ) will be held on Wednesday, May 19, 2027 in Gothenburg. Shareholders who wish to submit proposals to the Nomination Committee are welcome to do so in due time before the 2027 Annual General Meeting so that the Nomination Committee has time to consider the proposal. Proposals may be sent to Surgical Science Sweden AB (publ), Att: Nomination Committee, Drakegatan 7A, 412 50 Gothenburg, Sweden.

Gothenburg, Sweden, October 1, 2026
Surgical Science Sweden AB (publ)

The press release, in its entirety, is available through the attachment or via:
https://surgicalscience.com/investor-relations/#press-releases

 

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

Prompts

Surgical Science Sweden (ticker SUS), listed in Sweden.

ETFs Holding Surgical Science Sweden

ETF Weight in ETF Shares Market value As of
AVDS 0.01% 7,766 $ 44.005K Nov 16, 2026